Chronotherapeutic and Epigenetic Regulation of Circadian Rhythms: Nicotinamide Adenine Dinucleotide-Sirtuin Axis

키워드

참고문헌 (60)

1. Ayyar VS, "Circadian rhythms : influence on physiology, pharmacology, and therapeutic interventions", J Pharmacokinet Pharmacodyn, 48, pp.321~338 (2021)[DOI]
2. Van Drunen R, "Circadian rhythms of the hypothalamus : from function to physiology", Clocks Sleep, 3, pp.189~226 (2021)[DOI]
3. Maury E, "Off the clock : from circadian disruption to metabolic disease", Int J Mol Sci, 20, pp.1597~ (2019)[DOI]
4. Crnko S, "Circadian rhythms and the molecular clock in cardiovascular biology and disease", Nat Rev Cardiol, 16, pp.437~447 (2019)[DOI]
5. Logan RW, "Rhythms of life : circadian disruption and brain disorders across the lifespan", Nat Rev Neurosci, 20, pp.49~65 (2019)[DOI]
6. Mustafa M, "Molecular pathways and therapeutic targets linked to triple-negative breast cancer(TNBC)", Mol Cell Biochem, 479, pp.895~913 (2024)[DOI]
7. Ruan W, "Circadian rhythm as a therapeutic target", Nat Rev Drug Discov, 20, pp.287~307 (2021)[DOI]
8. Covarrubias AJ, "NAD+ metabolism and its roles in cellular processes during ageing", Nat Rev Mol Cell Biol, 22, pp.119~141 (2021)[DOI]
9. Imai S, ""Clocks"in the NAD world : NAD as a metabolic oscillator for the regulation of metabolism and aging", Biochim Biophys Acta, 1804, pp.1584~1590 (2010)[DOI]
10. Escalante-Covarrubias Q, "Time-of-day defines NAD+ efficacy to treat diet-induced metabolic disease by synchronizing the hepatic clock in mice", Nat Commun, 14, pp.1685~ (2023)[DOI]
11. Feldman JL, "Sirtuin catalysis and regulation", J Biol Chem, 287, pp.42419~42427 (2012)[DOI]
12. Grabowska W, "Sirtuins, a promising target in slowing down the ageing process", Biogerontology, 18, pp.447~476 (2017)[DOI]
13. Masri S, "Sirtuin-dependent clock control : new advances in metabolism, aging and cancer", Curr Opin Clin Nutr Metab Care, 18, pp.521~527 (2015)[DOI]
14. Osum M, "Impact of circadian disruption on health; SIRT1and telomeres", DNA Repair(Amst), 96, pp.102993~ (2020)[DOI]
15. Asher G, "SIRT1 regulates circadian clock gene expression through PER2 deacetylation", Cell, 134, pp.317~328 (2008)[DOI]
16. Wang Y, "SIRT6’s function in controlling the metabolism of lipids and glucose in diabetic nephropathy", Front Endocrinol(Lausanne), 14, pp.1244705~ (2023)[DOI]
17. Xie N, "NAD+ metabolism : pathophysiologic mechanisms and therapeutic potential", Signal Transduct Target Ther, 5, pp.227~ (2020)[DOI]
18. Levine DC, "Circadian NAD(P)(H)cycles in cell metabolism", Semin Cell Dev Biol, 126, pp.15~26 (2022)[DOI]
19. Navas LE, "NAD+ metabolism, stemness, the immune response, and cancer", Signal Transduct Target Ther, 6, pp.2~ (2021)[DOI]
20. Cambronne XA, "Location, location, location : compartmentalization of NAD+ synthesis and functions in mammalian cells", Trends Biochem Sci, 45, pp.858~873 (2020)[DOI]
21. Khoury N, "The NAD+-dependent family of sirtuins in cerebral ischemia and preconditioning", Antioxid Redox Signal, 28, pp.691~710 (2018)[DOI]
22. Bailey SM, "Circadian regulation of metabolism", J Endocrinol, 222, pp.R75~R96 (2014)[DOI]
23. Velma GR, "Channeling nicotinamide phosphoribosyltransferase(NAMPT)to address life and death", J Med Chem, 67, pp.5999~6026 (2024)[DOI]
24. Sharma P, "Inhibition of nicotinamide phosphoribosyltransferase(NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide(NAD)salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress", Neuro Oncol, 24, pp.229~244 (2022)[DOI]
25. Li W, "NMNAT2 : an important metabolic enzyme affecting the disease progression", Biomed Pharmacother, 158, pp.114143~ (2023)[DOI]
26. Nakahata Y, "The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control", Cell, 134, pp.329~340 (2008)[DOI]
27. Kumar V, "PARP around the clock", Cell, 142, pp.841~843 (2010)[DOI]
28. Kumar S, "Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology", Crit Rev Biochem Mol Biol, 53, pp.311~334 (2018)[DOI]
29. Roh E, "Hypothalamic NAD+-sirtuin axis : function and regulation", Biomolecules, 10, pp.396~ (2020)[DOI]
30. Kaufmann T, "SIRT2 regulates nuclear envelope reassembly through ANKLE2 deacetylation", J Cell Sci, 129, pp.4607~4621 (2016)[DOI]
31. Kumar S, "Mitochondrial sirtuins and their relationships with metabolic disease and cancer", Antioxid Redox Signal, 22, pp.1060~1077 (2015)[DOI]
32. Lombard DB, "SIRT6 in DNA repair, metabolism and ageing", J Intern Med, 263, pp.128~141 (2008)[DOI]
33. Tsai YC, "Sirtuin 7 plays a role in ribosome biogenesis and protein synthesis", Mol Cell Proteomics, 13, pp.73~83 (2014)[DOI]
34. Raj S, "Sirt6 deacetylase : a potential key regulator in the prevention of obesity, diabetes and neurodegenerative disease", Front Pharmacol, 11, pp.598326~ (2020)[DOI]
35. Cantó C, "PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure", Curr Opin Lipidol, 20, pp.98~105 (2009)[DOI]
36. Dzidek A, "The role of increased expression of sirtuin 6 in the prevention of premature aging pathomechanisms", Int J Mol Sci, 24, pp.9655~ (2023)[DOI]
37. Lee Y, "Multi-modal regulation of circadian physiology by interactive features of biological clocks", Biology(Basel), 11, pp.21~ (2021)[DOI]
38. Escobar C, "Circadian disruption leads to loss of homeostasis and disease", Sleep Disord, 2011, pp.964510~ (2011)[DOI]
39. Potter GD, "Circadian rhythm and sleep disruption : causes, metabolic consequences, and countermeasures", Endocr Rev, 37, pp.584~608 (2016)[DOI]
40. Voigt RM, "Circadian disruption : potential implications in inflammatory and metabolic diseases associated with alcohol", Alcohol Res, 35, pp.87~96 (2013)
41. Strømland Ø, "The balance between NAD+ biosynthesis and consumption in ageing", Mech Ageing Dev, 199, pp.111569~ (2021)[DOI]
42. Aman Y, "Therapeutic potential of boosting NAD+in aging and age-related diseases", Transl Med Aging, 2, pp.30~37 (2018)[DOI]
43. Poljšak B, "The central role of the NAD+molecule in the development of aging and the prevention of chronic age-related diseases : strategies for NAD+ modulation", Int J Mol Sci, 24, pp.2959~ (2023)[DOI]
44. Kalous KS, "Mechanism of Sirt1NAD+-dependent protein deacetylase inhibition by cysteine S-nitrosation", J Biol Chem, 291, pp.25398~25410 (2016)[DOI]
45. Pardo PS, "SIRT1 regulation in ageing and obesity", Mech Ageing Dev, 188, pp.111249~ (2020)[DOI]
46. Li F, "Adipose-specific knockdown of Sirt1 results in obesity and insulin resistance by promoting exosomes release", Cell Cycle, 18, pp.2067~2082 (2019)[DOI]
47. Tasselli L, "SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence", Nat Struct Mol Biol, 23, pp.434~440 (2016)[DOI]
48. Soni SK, "Sirtuins and the circadian clock interplay in cardioprotection : focus on sirtuin 1", Cell Mol Life Sci, 78, pp.2503~2515 (2021)[DOI]
49. Rajman L, "Therapeutic potential of NADboosting molecules : the in vivo evidence", Cell Metab, 27, pp.529~547 (2018)[DOI]
50. Sharma A, "Potential synergistic supplementation of NAD+ promoting compounds as a strategy for increasing healthspan", Nutrients, 15, pp.445~ (2023)[DOI]
51. Chen Z, "Development and therapeutic potential of small-molecule modulators of circadian systems", Annu Rev Pharmacol Toxicol, 58, pp.231~252 (2018)[DOI]
52. Bellet MM, "Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1", Proc Natl Acad Sci U S A, 110, pp.3333~3338 (2013)[DOI]
53. Alegre GFS, "NAD+ precursors nicotinamide mononucleotide(NMN)and nicotinamide riboside(NR) : potential dietary contribution to health", Curr Nutr Rep, 12, pp.445~464 (2023)[DOI]
54. Niu KM, "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase", Front Nutr, 8, pp.756243~ (2021)[DOI]
55. Bai P, "PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation", Cell Metab, 13, pp.461~468 (2011)[DOI]
56. Xu J, "Brain SIRT1mediates metabolic homeostasis and neuroprotection", Front Endocrinol(Lausanne), 9, pp.702~ (2018)[DOI]
57. Jung-Hynes B, "Sirtuins, melatonin and circadian rhythms : building a bridge between aging and cancer", J Pineal Res, 48, pp.9~19 (2010)[DOI]
58. Dobrek L, "Chronopharmacology in therapeutic drug monitoring—dependencies between the rhythmics of pharmacokinetic processes and drug concentration in blood", Pharmaceutics, 13, pp.1915~ (2021)[DOI]
59. Manoogian ENC, "Circadian rhythms, time-restricted feeding, and healthy aging", Ageing Res Rev, 39, pp.59~67 (2017)[DOI]
60. Chaix A, "Time-restricted eating to prevent and manage chronic metabolic diseases", Annu Rev Nutr, 39, pp.291~315 (2019)[DOI]

관련 논문AI추천